ATHEROSCLEROTIC LESION PHANTOM (ALP) FOR MRI/A
用于 MRI/A 的动脉粥样硬化病变体模 (ALP)
基本信息
- 批准号:6294879
- 负责人:
- 金额:$ 12.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-03-12 至 2002-03-13
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Applicant's abstract verbatim): Development of MRI techniques,
optimized for cardiovascular disease (CVD) applications, are currently hampered
by low signal to noise ratios (SNR), tissue motion and blood flow artifacts.
The long term goal of this project is to develop an Atherosclerotic Lesion
Phantom (ALP) to assist the MRI community develop non invasive applications to
identify patients at risk for clinically acute CV syndromes. This will be
accomplished by: 1) accurately modeling the morphology of key pathogenic
features associated with high risk atherosclerotic lesions and 2) providing a
controlled environment that reproduces the difficulties associated with
clinical imaging. ALP combines the benefits of existing technologies with: an
innovative artificial artery including multiple wall layers (Aim 1), stenotic
lesions that mimic the morphology (Aim 2) and MRI content (T1, T2, contrast) of
atherosclerotic lesions in a stable and well characterized manner (Aim 3). In
Phase II, we focus on optimizing materials and procedures identified in Phase I
in anticipation of constructing advanced flow phantoms for Phase III product
evaluation. A comprehensive ALP will be critical for the development and
validation of new clinical applications as well as in training medical
personnel on using state of the art MRI screening protocols for atherosclerotic
CVD.
PROPOSED COMMERCIAL APPLICATION:
The magnitude of the clinical need for a non invasive means to identify patients at risk for
plaque rupture or erosion is so large and the commercial availability of adequate MRI tools
so limited as to create a lucrative market niche for a highly advanced atherosclerotic lesion
phantom targeted at cardiovascular disease. Products developed from this project will
address current and future needs in clinical research, QA, and personnel training
applications.
描述(申请人摘要逐字):MRI技术的发展;
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS M BURKE其他文献
THOMAS M BURKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS M BURKE', 18)}}的其他基金
mCAP: Enabling Technology for MRI Visible Polymers
mCAP:MRI 可见聚合物的支持技术
- 批准号:
6786938 - 财政年份:2004
- 资助金额:
$ 12.79万 - 项目类别:
Slipstream Visualization Technology for MRI/A Phantoms
MRI/A 体模的滑流可视化技术
- 批准号:
6630710 - 财政年份:2003
- 资助金额:
$ 12.79万 - 项目类别:
ECAD:Enhanced Coronary Artery Disease Phantom for MRA
ECAD:MRA 增强型冠状动脉疾病模型
- 批准号:
6738607 - 财政年份:2001
- 资助金额:
$ 12.79万 - 项目类别:
Atherosclerotic Lesion Phantom (ALP) for MRI/A
用于 MRI/A 的动脉粥样硬化病变体模 (ALP)
- 批准号:
7124605 - 财政年份:2001
- 资助金额:
$ 12.79万 - 项目类别:
Atherosclerotic Lesion Phantom (ALP) for MRI/A
用于 MRI/A 的动脉粥样硬化病变体模 (ALP)
- 批准号:
6879296 - 财政年份:2001
- 资助金额:
$ 12.79万 - 项目类别:
ECAD: Enhanced Coronary Artery Disease Phantom for MRA
ECAD:MRA 增强型冠状动脉疾病模型
- 批准号:
6402326 - 财政年份:2001
- 资助金额:
$ 12.79万 - 项目类别:
ECAD:Enhanced Coronary Artery Disease Phantom for MRA
ECAD:MRA 增强型冠状动脉疾病模型
- 批准号:
6990547 - 财政年份:2001
- 资助金额:
$ 12.79万 - 项目类别:
ECAD:Enhanced Coronary Artery Disease Phantom for MRA
ECAD:MRA 增强型冠状动脉疾病模型
- 批准号:
6836069 - 财政年份:2001
- 资助金额:
$ 12.79万 - 项目类别:
Enhanced carotid bifurcation phantom for MRI/A
用于 MRI/A 的增强型颈动脉分叉体模
- 批准号:
6622204 - 财政年份:2000
- 资助金额:
$ 12.79万 - 项目类别:
ENHANCED CAROTID BIFURCATION PHANTOM FOR MRI/A
用于 MRI/A 的增强型颈动脉分叉体模
- 批准号:
6208607 - 财政年份:2000
- 资助金额:
$ 12.79万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 12.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 12.79万 - 项目类别:














{{item.name}}会员




